We have set up a clear vision for Nordmark's future. This definition allows us to invest specifically in the skills and technology needed in our focus areas. Dr Jörn Tonne, CEO and Managing Director
We have set up a clear vision for Nordmark's future. This definition allows us to invest specifically in the skills and technology needed in our focus areas.
Dr Jörn Tonne, CEO and Managing Director
Quality products, service material and high delivery capacity: our mix for ideal patient care. Volker Kahrmann, Head of Marketing
Quality products, service material and high delivery capacity: our mix for ideal patient care.
Volker Kahrmann, Head of Marketing
Innovation plays a prominent role for us. On the one hand, in the further development and optimisation of our existing business. On the other hand, we are developing into new fields, such as hormone replacement therapy and the isolation and proliferation of stem cells. Dr Jörn Tonne, CEO and Managing Director
Innovation plays a prominent role for us. On the one hand, in the further development and optimisation of our existing business. On the other hand, we are developing into new fields, such as hormone replacement therapy and the isolation and proliferation of stem cells.
07/03/2024
Read more
03/01/2024
02/19/2024
09/05/2023
The Nordmark Biochemicals team is happy to be there for you on site!
08/11/2023
Norbitec biotech facility in Uetersen, Germany, a company controlled by STADA, passes inspection by the US Food and Drug Administration (FDA).
07/31/2023
Try our Neutral Protease NB enzymes!
07/04/2023
During the 55th European Pancreatic Club meeting on 29th June 2023, Dr Juliane Glaubitz from Greifswald was awarded the Rudolf Ammann Award 2023.
05/11/2023
10 Years of Successful Islet Cell Isolation
03/03/2023
At the general meeting of the DPC on 03.03.2023, Mr Kaan Cifcibasi from Munich was awarded the Werner Creutzfeldt Doctoral Scholarship 2022.